Stage IV Cutaneous Melanoma AJCC v6 and v7 Active Not Recruiting Phase 2 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0091050 (Stage IV Cutaneous Melanoma AJCC v6 and v7)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01950390Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by SurgeryTreatment